As you have read this week about the financial details of Facebook’s IPO filing, you have no doubt stopped to think about—or daydream about—what your own company might be worth. While going public might be a distant or inappropriate goal for your own venture, Facebook’s IPO serves as a timely reminder that you should be … Continue reading “To Attract Investors, Put Your Best Financial Foot Forward”
Author: Aftab Jamil
Aftab Jamil is a partner and national director of the Technology and Life Sciences Practice at BDO USA, LLP. He has over 17 years of experience in public accounting, including substantial experience in serving medical device, life sciences and technology sectors. Aftab has served public and private companies ranging from start-up, development stage enterprises to established multinational companies.
Innovate or Conserve Cash? The Growing Dilemma for Biotech Firms
There’s no doubt that managing a biotech company is an enduring challenge, even during less tumultuous economic times. Now, entrepreneurs are contending with resources that are incredibly tight, an economy that is unsettled, a stock market on a roller-coaster ride, and research and development budgets that are being slashed. The stewardship role entrusted to the … Continue reading “Innovate or Conserve Cash? The Growing Dilemma for Biotech Firms”